I am excited to announce that there is now a working prototype for an online, interactive implementation of my Accumulating Evidence and Research Organization (AERO) graph over at PortalResearch.org (here’s a link to the original methods paper). The goal of this tool is to allow many different research stakeholders (e.g., regulators, ethics committees, patients) to more effectively communicate about the total state of evidence in a given scientific domain and then make more informed decisions on the basis of that evidence. You can check it out here!
Hey SP (2017). Ethical Challenges in Biomarker-Driven Drug Development. Clinical Pharmacology & Therapeutics doi:10.1002/cpt.862.
Hey SP, Cohen IG, Adashi EY, Kesselheim AS (2017). Influence, Integrity, and the FDA: An Ethical Framework Science 357(6354):876-877.
Hey SP, Franklin JM, Avorn J, Kesselheim AS (2017). Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors Circulation: Cardiovascular Quality and Outcomes 10(6):e003121.
Hey SP & Barsanti-Innes B (2017). Epistemology, Ethics, and Progress in Precision Medicine. Perspectives in Biology and Medicine 59(3):293-310.
Since 2015, I have been a faculty member at the Harvard Center for Bioethics and a research fellow in the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology & Pharmacoeconomics at the Brigham and Women’s Hospital in Boston, Massachusetts.
I received my Ph.D. in philosophy from the University of Western Ontario and my B.A. in philosophy from the University of Illinois at Chicago. I previously held a research fellowship in the Biomedical Ethics Unit at McGill University and a visiting scholarship in the Ethox Centre at the University of Oxford.
You can now also follow me on twitter!